Your browser doesn't support javascript.
loading
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.
Walter, I; Schulz, U; Vogelhuber, M; Wiedmann, K; Endlicher, E; Klebl, F; Andreesen, R; Herr, W; Ghibelli, L; Hackl, C; Wiest, R; Reichle, A.
Afiliación
  • Walter I; Health Center Alte Mälzerei, Regensburg, Germany.
  • Schulz U; Department Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Vogelhuber M; Department Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Wiedmann K; Hospital Barmherzige Brüder Regensburg, Regensburg, Germany.
  • Endlicher E; Health Center Regensburg, Regensburg, Germany.
  • Klebl F; Health Center Alte Mälzerei, Regensburg, Germany.
  • Andreesen R; Department Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Herr W; Department Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Ghibelli L; Department of Biology, Universita' di Roma Tor Vergata, Rome, Italy.
  • Hackl C; Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.
  • Wiest R; University Hospital for Visceral Surgery and Medicine Gastroenterology, Bern, Switzerland.
  • Reichle A; Department Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany. albrecht.reichle@ukr.de.
Med Oncol ; 34(12): 192, 2017 Nov 02.
Article en En | MEDLINE | ID: mdl-29098441

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Inhibidores de la Ciclooxigenasa 2 / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Inhibidores de la Ciclooxigenasa 2 / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania